Defining Mechanisms of Surgical Site Infection After Oral Cancer Surgery
ConditionOral Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age21+
SponsorMedical College of Wisconsin
About this trial
The study design is an observational cohort study of patients undergoing standard of care oral cavity reconstruction. An observational study is required to prospectively evaluate microbial and antibiotic mechanisms underlying surgical site infection after oral cavity reconstruction.
Eligibility criteria
Qualifiers
Provide signed and dated informed consent form. Subjects must have the capacity to consent for themselves.
Willing to comply with all study procedures and be available for the duration of the study.
Aged 21 years or older.
Planned to undergo standard of care oral cavity reconstruction surgery with use of ampicillin/sulbactam as the prophylactic antibiotic agent administered.
Disqualifiers
Allergy to ampicillin/sulbactam.
Vulnerable populations including pregnant women and prisoners.
Trial design
Treatments tested in this trial
- Oral Cavity Reconstruction
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Medical College of Wisconsin
Lead sponsor
National Institute of Dental and Craniofacial Research (NIDCR)
Collaborator
Source ClinicalTrials.gov